Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

peritoneal multicystic mesothelioma - Clinical Profile, Genes & Research | Kisho | Kisho

Rare Disease

peritoneal multicystic mesothelioma

MONDO:0006363

Also known as:multicystic mesotheliomamulticystic mesothelioma of peritoneummulticystic mesothelioma of the peritoneum

Overview

A cystic mesothelioma that arises from the peritoneum and usually affects young to middle aged females. Grossly, it presents as a large multiloculated tumor mass, usually in the pelvic peritoneum. Histologically it is characterized by the presence of multiple cysts that are lined by one or more layers of mesothelial cells that do not show atypia. Patients usually present with abdominal or pelvic mass and pain. The clinical course is indolent. The tumor may recur, but transformation to diffuse malignant mesothelioma is rare.

Clinical Presentation

Built from Human Phenotype Ontology (HPO) phenotype annotations and GeneReviews clinical descriptions. Features represent findings documented across known cases — not an exhaustive list of possible symptoms.

Features include very common findings: Constipation, Abdominal pain, Peritonitis, and Neoplasm and others; and common findings: Menorrhagia, Weight loss, Dyspareunia, and Metrorrhagia.

Organ System	Phenotype Count	Example Features
Digestive system	3	Constipation, Abdominal pain, Abdominal distention

Diagnosis

Biomarker and diagnostic research for peritoneal multicystic mesothelioma has been reported in the published literature.

Prognosis

Phenotype severity distribution: 5 very common features, 4 common features.

Estimated prevalence: Unknown (Unknown prevalence).

Research Landscape

Sourced from ClinicalTrials.gov and PubMed. Publication types are classified using NLM-curated article metadata; research type breakdowns reflect the nature of published work for this disease.

No clinical trials have been registered for peritoneal multicystic mesothelioma.

17 publications have been identified in PubMed for peritoneal multicystic mesothelioma. Research spans Case Report / Case Series (65%), Other (12%), and Diagnostic / Biomarker (6%).

Research Type	Count	% of Total
Patient case studies	11	65%

Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:05 PM UTC

MONDOHPOClinicalTrials.govFDAPubMedHGNCClinVarClinGenGeneReviewsOrphanetOMIMRUSP

Medical References

External Resources

Orphanet

European rare disease database

Orphanet:168816

GARD

Genetic and Rare Diseases Info Center

GARD:10777

Questions for Your Care Team

→Are there specialists or centers of excellence for this condition in my area?
→Is there a patient registry I should consider joining?

← Back to All Diseases

Kisho

peritoneal multicystic mesothelioma

Overview

Clinical Presentation

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

Explore clinical features

Recent Publications

Latest News & Developments

Genomic sequencing of multicystic mesothelioma finds cohesin complex mutations associated with disease recurrence in patients referred for cytoreductive surgery and HIPEC.

peritoneal multicystic mesothelioma

Overview

Clinical Presentation

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

Explore clinical features

Recent Publications

Latest News & Developments

Genomic sequencing of multicystic mesothelioma finds cohesin complex mutations associated with disease recurrence in patients referred for cytoreductive surgery and HIPEC.